FDA Investigator Ramesh Potla, PhD
Ramesh Potla, PhD has conducted inspections on 9 sites in 6 countries as of 21 Aug 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
21 Aug 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Puerto Rico,
China,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Switzerland,
Japan
FDA Investigators that have inspected at least one site in common with Ramesh Potla, PhD:
Adaliz Santaliz Cruz,
Alan A Rivera,
Anastasia G Lolas,
Anders W Evenson,
Andrea George, PhD,
Ann Marie Montemurro,
Arlene M Badillo,
Ashley N Queen, PhD,
Bo Chi, PhD,
Brandon C Heitmeier,
Brian D Nicholson,
Calvin B Koerner,
Carl A Anderson,
Charles I Ann,
Charles M Edwards,
Chen Sun, PhD,
Chikako Torigoe, PhD,
Christopher D Leach,
Christopher Downey, PhD,
Christopher T Middendorf,
Colleen Thomas, PhD,
Cynthia Jim, CSO,
Dennis Cantellops Paite,
Diane L Raccasi,
Donald C Obenhuber, PhD,
Dov H Pluznik, PhD,
Dr. Jun Liu, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Eliezar Ramos,
Erika V Butler,
Francis A Guidry,
Gwyn G Dickinson,
Helen B Ricalde,
Ivis L Negron,
Jacek Cieslak, PhD,
Jennifer Lalama,
Jerri Baker,
Jonathan W Chapman,
Jorge L Lajara,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose M Cayuela,
Jose R Lopez,
Jose Velez,
Julie D Bringger,
Justin A Boyd,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Kim Lthomas Cruse,
Larry K Austin,
Laurimer Kuilan Torres,
Libia M Lugo,
Linda Thai,
Lindsey S Fleischman,
LT Rafael Gonzalez,
Madushini Dharmasena, PhD,
Maria Gutierrez Hoffman, PhD,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Marie F Morin,
Marion Michaelis,
Maxwell Van Tassell, PhD,
Mekonnen Lemma Dechassa, PhD,
Merry Christie, PhD,
Michael A Charles,
Michael Shanks, MS,
Michelle Yclark Stuart,
Milva E Melendez Perales,
Minh D Phan,
Muna Algharibeh,
Myriam M Sosa,
Nibin Varghese, MS,
Nicholas Obiri, PhD,
Nikolay Spiridonov,
Noreen Muñiz,
Nydia E Colon,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Paul Z Balcer,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebecca E Dombrowski,
Rebecca Parrilla,
Rebecca Rodriguez,
Riley C Myers, PhD,
Robert C Coleman,
Robert Darius,
Robert J Martin,
Rong Wang, PhD,
Scott R Nichols, PhD,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Stephen D Brown,
Steven C Madzo,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Susan M Jackson,
Thomas E Friel,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy Wadkin, PhD,
Tracy Denison, PhD,
Vaishali J Patel,
Vilmary Negron Rodriguez,
Wendy G Tan, PhD,
Yanming An, PhD,
Yasamin Ameri,
Zachary L Stamm,
Zhong Li, PhD
Ramesh Potla, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2019 | FDA 483 | Kashiv BioSciences, LLC - Form 483, 2019-03-12 |
| December, 2017 | FDA 483 | Kyowa Kirin Co., Ltd. - Form 483, 2017-12-21 |
| March, 2014 | FDA 483 | Amgen Manufacturing Limited LLC - Form 483, 2014-03-29 |
| March, 2016 | FDA 483 | Astellas Pharma Inc. - Form 483, 2016-03-18 |
| August, 2019 | FDA 483 | Novartis Pharma AG - Form 483, 2019-08-29 |
| April, 2019 | EIR | WuXi Biologics Co., Ltd. - EIR, 2019-04-16 |
| August, 2017 | FDA 483 | WuXi Biologics Co., Ltd. - Form 483, 2017-08-02 |
| April, 2019 | FDA 483 | WuXi Biologics Co., Ltd. - Form 483, 2019-04-16 |
| January, 2017 | EIR | AbbVie Biotechnology LTD - EIR, 2017-01-13 |
| March, 2019 | EIR | Kashiv BioSciences, LLC - EIR, 2019-03-12 |
| August, 2018 | FDA 483 | Porton Biopharma Limited - Form 483, 2018-08-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more